Nhs England
July 4
14:45
2023
Details
From 1 September 2023, all newly eligible individuals will be offered 2 doses of the non-live shingles vaccine Shingrix instead of Zostavax and eligibility for the immunocompromised and immunocompetent cohorts will change.
This letter provides further details and links to the supporting programme guidance and materials for health professionals who are responsible for commissioning and operationally delivering the programme.